15-deoxy-Δ 12,14-prostaglandin J 2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice

Hepatology

Volumn 56, Issue 1, 2012, Pages 350-360

  Han, Zhen ^a   Zhu, Tieping ^a   Liu, Xihong ^a   Li, Changyong ^a   Yue, Shi ^a   Liu, Xin ^a   Yang, Le ^a   Yang, Lin ^a   Li, Liying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CARBON TETRACHLORIDE; ENHANCED GREEN FLUORESCENT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL MIGRATION; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG SCREENING; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LIVER CIRRHOSIS; MACROPHAGES; MICE; MICE, TRANSGENIC; PHAGOCYTOSIS; PROSTAGLANDIN D2; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84863503151     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25672     Document Type: Article

References (33)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
2. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis 2007; 27: 339-350.
3. Kallis YN, Forbes SJ. The bone marrow and liver fibrosis: friend or foe? Gastroenterology 2009; 137: 1218-1221.
4. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007; 56: 716-724.
5. Li CY, Jiang XM, Yang L, Liu XH, Yue S, Li LY. Involvement of sphingosine 1-phosphate (SIP)/S1P(3) signaling in cholestasis-induced liver fibrosis. Am J Pathol 2009; 175: 1464-1472.
6. Li CY, Kong YX, Wang H, Wang SL, Yu H, Liu X, et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 2009; 50: 1174-1183.
7. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 2009; 119: 1858-1870.
8. Marra F, Aleffi S, Galastri S, Provenzano A. Mononuclear cells in liver fibrosis. Semin Immunopathol 2009; 31: 345-358.
9. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, et al. Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages. Blood 2007; 110: 4077-4085.
10. Scher JU, Pillinger MH. 15d-PGJ(2): the anti-inflammatory prostaglandin? Clin Immunol 2005; 114: 100-109.
11. Diers AR, Dranka BP, Ricart KC, Oh JY, Johnson MS, Zhou F, Pallero MA, Bodenstine TM, Murphy-Ullrich JE, Welch DR, Landar A. Modulation of mammary cancer cell migration by 15-deoxy-Delta(12, 14)-prostaglandin J(2): implications for anti-metastatic therapy. Biochemical Journal 2010; 430: 69-78.
12. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-478.
13. Napimoga MH, Vieira SM, Dal-Secco D, Freitas A, Souto FO, Mestriner FL, et al. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta A(12, 14)-prostaglandin J(2), reduces neutrophil migration via a nitric oxide pathway. J Immunol 2008; 180: 609-617.
14. Reddy RC, Narala VR, Keshamouni VG, Milam JE, Newstead MW, Standiford TJ. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-gamma. Blood 2008; 112: 4250-4258.
15. Baeck C, Wehr A, Karlmark KR, Gassler N, Huss S, Luedde T, et al. Pharmacological inhibition of the chemokine Ccl2 (Mcp-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. HEPATOLOGY 2011; 54: 1155A-1155A.
16. Liu XH, Yue S, Li CY, Yang L, You H, Li LY. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation. J Cell Physiol 2011; 226: 2370-2377.
17. Lee CM, Yeoh GC, Olynyk JK. Differential effects of gadolinium chloride on Kupffer cells in vivo and in vitro. Int J Biochem Cell Biol 2004; 36: 481-488.
18. Li CY, Zheng SJ, You H, Liu XH, Lin MH, Yang L, et al. Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. J Hepatol 2011; 54: 1205-1213.
19. Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S, et al. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 2010; 53: 903-910.
20. Jiang CY, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
21. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
22. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7: 48-52.
23. Li LY, Tao JC, Davaille J, Feral C, Mallat A, Rieusset J, et al. 15-deoxy-Delta(12, 14)-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts - a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J Biol Chem 2001; 276: 38152-38158.
24. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. HEPATOLOGY 2003; 38: 1188-1198.
25. Su CG, Wen XM, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999; 104: 383-389.
26. Alves CF, de Melo NFS, Fraceto LF, de Araujo DR, Napimoga MH. Effects of 15d-PGJ(2)-loaded poly(D, L-lactide-co-glycolide) nanocapsules on inflammation. Br J Pharmacol 2011; 162: 623-632.
27. Kim EH, Surh YJ. 15-deoxy-Delta(12, 14)-prostaglandin J(2) as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006; 72: 1516-1528.
28. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669.
29. Li LY, Grenard P, Van Nhieu JT, Julien B, Mallat A, Habib A, et al. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 2003; 125: 460-468.
30. Li LY, Julien B, Grenard P, Teixeira-Clerc F, Mallat A, Lotersztajn S. Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. J Hepatol 2004; 41: 407-413.
31. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, et al. PPAR gamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1146-L1153.
32. Li YJ, Wen XY, Spataro BC, Hu KB, Dai CS, Liu YH. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J Am Soc Nephrol 2006; 17: 54-65.
33. Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function. Clin Exp Pharmacol Physiol 2009; 36: 478-486.